Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease
ARH3/ADPRHL2 and PARG are the primary enzymes reversing ADP-ribosylation in vertebrates, yet their functions in vivo remain unclear. ARH3 is the only hydrolase able to remove serine-linked mono(ADP-ribose) (MAR) but is much less efficient than PARG against poly(ADP-ribose) (PAR) chains in&a...
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Cell Press
2021
|
| _version_ | 1797060262235209728 |
|---|---|
| author | Prokhorova, E Agnew, T Wondisford, AR Tellier, M Kaminski, N Beijer, D Holder, J Groslambert, J Suskiewicz, MJ Zhu, K Reber, JM Krassnig, SC Palazzo, L Murphy, S Nielsen, ML Mangerich, A Ahel, D Baets, J O'Sullivan, RJ Ahel, I |
| author_facet | Prokhorova, E Agnew, T Wondisford, AR Tellier, M Kaminski, N Beijer, D Holder, J Groslambert, J Suskiewicz, MJ Zhu, K Reber, JM Krassnig, SC Palazzo, L Murphy, S Nielsen, ML Mangerich, A Ahel, D Baets, J O'Sullivan, RJ Ahel, I |
| author_sort | Prokhorova, E |
| collection | OXFORD |
| description | ARH3/ADPRHL2 and PARG are the primary enzymes reversing ADP-ribosylation in vertebrates, yet their functions in vivo remain unclear. ARH3 is the only hydrolase able to remove serine-linked mono(ADP-ribose) (MAR) but is much less efficient than PARG against poly(ADP-ribose) (PAR) chains in vitro. Here, by using ARH3-deficient cells, we demonstrate that endogenous MARylation persists on chromatin throughout the cell cycle, including mitosis, and is surprisingly well tolerated. Conversely, persistent PARylation is highly toxic and has distinct physiological effects, in particular on active transcription histone marks such as H3K9ac and H3K27ac. Furthermore, we reveal a synthetic lethal interaction between ARH3 and PARG and identify loss of ARH3 as a mechanism of PARP inhibitor resistance, both of which can be exploited in cancer therapy. Finally, we extend our findings to neurodegeneration, suggesting that patients with inherited ARH3 deficiency suffer from stress-induced pathogenic increase in PARylation that can be mitigated by PARP inhibition. |
| first_indexed | 2024-03-06T20:14:43Z |
| format | Journal article |
| id | oxford-uuid:2bc20d4c-0888-4e8b-a0a3-33e89ecc43c3 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:14:43Z |
| publishDate | 2021 |
| publisher | Cell Press |
| record_format | dspace |
| spelling | oxford-uuid:2bc20d4c-0888-4e8b-a0a3-33e89ecc43c32022-03-26T12:32:54ZUnrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human diseaseJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2bc20d4c-0888-4e8b-a0a3-33e89ecc43c3EnglishSymplectic ElementsCell Press2021Prokhorova, EAgnew, TWondisford, ARTellier, MKaminski, NBeijer, DHolder, JGroslambert, JSuskiewicz, MJZhu, KReber, JMKrassnig, SCPalazzo, LMurphy, SNielsen, MLMangerich, AAhel, DBaets, JO'Sullivan, RJAhel, IARH3/ADPRHL2 and PARG are the primary enzymes reversing ADP-ribosylation in vertebrates, yet their functions in vivo remain unclear. ARH3 is the only hydrolase able to remove serine-linked mono(ADP-ribose) (MAR) but is much less efficient than PARG against poly(ADP-ribose) (PAR) chains in vitro. Here, by using ARH3-deficient cells, we demonstrate that endogenous MARylation persists on chromatin throughout the cell cycle, including mitosis, and is surprisingly well tolerated. Conversely, persistent PARylation is highly toxic and has distinct physiological effects, in particular on active transcription histone marks such as H3K9ac and H3K27ac. Furthermore, we reveal a synthetic lethal interaction between ARH3 and PARG and identify loss of ARH3 as a mechanism of PARP inhibitor resistance, both of which can be exploited in cancer therapy. Finally, we extend our findings to neurodegeneration, suggesting that patients with inherited ARH3 deficiency suffer from stress-induced pathogenic increase in PARylation that can be mitigated by PARP inhibition. |
| spellingShingle | Prokhorova, E Agnew, T Wondisford, AR Tellier, M Kaminski, N Beijer, D Holder, J Groslambert, J Suskiewicz, MJ Zhu, K Reber, JM Krassnig, SC Palazzo, L Murphy, S Nielsen, ML Mangerich, A Ahel, D Baets, J O'Sullivan, RJ Ahel, I Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease |
| title | Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease |
| title_full | Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease |
| title_fullStr | Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease |
| title_full_unstemmed | Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease |
| title_short | Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease |
| title_sort | unrestrained poly adp ribosylation provides insights into chromatin regulation and human disease |
| work_keys_str_mv | AT prokhorovae unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT agnewt unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT wondisfordar unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT tellierm unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT kaminskin unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT beijerd unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT holderj unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT groslambertj unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT suskiewiczmj unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT zhuk unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT reberjm unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT krassnigsc unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT palazzol unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT murphys unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT nielsenml unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT mangericha unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT aheld unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT baetsj unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT osullivanrj unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease AT aheli unrestrainedpolyadpribosylationprovidesinsightsintochromatinregulationandhumandisease |